Natural killer cell adoptive immunotherapy: Coming of age
- 1 April 2017
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 177, 3-11
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (401086/2014-3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 153 references indexed in Scilit:
- Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cellsCancer Immunology, Immunotherapy, 2011
- Expression of cDNAs in Human Natural Killer Cell Lines by Retroviral Transduction2009
- Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patientsBone Marrow Transplantation, 2009
- Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cellsLeukemia Research, 2009
- Adoptive cell therapy for the treatment of patients with metastatic melanomaCurrent Opinion in Immunology, 2009
- Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assaysImmunobiology, 2008
- Use of natural killer cells as immunotherapy for leukaemiaBest Practice & Research Clinical Haematology, 2008
- A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: Comparisons to a 4 h 51Cr-release assayJournal of Immunological Methods, 2007
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine designNature Reviews Immunology, 2006
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005